Correlation Between Evogene and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Evogene and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Protalix Biotherapeutics, you can compare the effects of market volatilities on Evogene and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Protalix Biotherapeutics.
Diversification Opportunities for Evogene and Protalix Biotherapeutics
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Evogene and Protalix is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Evogene i.e., Evogene and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Evogene and Protalix Biotherapeutics
Given the investment horizon of 90 days Evogene is expected to under-perform the Protalix Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Evogene is 1.5 times less risky than Protalix Biotherapeutics. The stock trades about -0.45 of its potential returns per unit of risk. The Protalix Biotherapeutics is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest 108.00 in Protalix Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 61.00 from holding Protalix Biotherapeutics or generate 56.48% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Evogene vs. Protalix Biotherapeutics
Performance |
Timeline |
Evogene |
Protalix Biotherapeutics |
Evogene and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evogene and Protalix Biotherapeutics
The main advantage of trading using opposite Evogene and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.Evogene vs. Eliem Therapeutics | Evogene vs. HCW Biologics | Evogene vs. Scpharmaceuticals | Evogene vs. Milestone Pharmaceuticals |
Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |